Home›Companies›Biotech & Pharma›Ensoma

Ensoma, Inc.

Updated Oct 27, 2026·Latest SEC filing May 23, 2023·Suggest an edit

About Ensoma

Ensoma is a private company based in Boston, Massachusetts, incorporated in 2019 in Delaware. It has reported $169,550,377 raised in two offerings on Form D since February 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 23, 2022Jan 9, 2023amended May 23, 2023$129,000,467fully sold22$5.8MEquityRule 506(b)Form D/A ↗1 earlier filing
Feb 5, 2021Feb 19, 2021$40,549,910of $70.5M target11$3.6MEquity, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$169,550,377

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ensoma's Form D filed May 23, 2023.

NS
Nihal Sinha
Director
EN
Emile Nuwaysir
Executive officer and director
KP
Kush Parmar
Director
KH
MC
Mark Chin
Director
AS

Earlier filings also listed Stephen Knight (director, last listed Feb 2021).

Sources

  1. SECEnsoma, Inc. Form D, filed Jan 9, 2023
  2. SECEnsoma, Inc. filing history